Phibro Animal Health (PAHC) Releases FY 2019 Earnings Guidance

Phibro Animal Health (NASDAQ:PAHC) updated its FY 2019 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $1.68-1.72 for the period, compared to the Thomson Reuters consensus estimate of $1.75. The company issued revenue guidance of $850-875 million, compared to the consensus revenue estimate of $863.99 million.

A number of equities research analysts recently commented on the company. BidaskClub raised Phibro Animal Health from a hold rating to a buy rating in a research note on Wednesday, August 8th. Zacks Investment Research raised Phibro Animal Health from a sell rating to a buy rating and set a $53.00 price objective for the company in a research note on Thursday, August 30th. Finally, Morgan Stanley lifted their price objective on Phibro Animal Health from $36.00 to $46.00 and gave the stock an underweight rating in a research note on Wednesday, August 29th. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of Hold and an average target price of $43.20.

Shares of Phibro Animal Health stock traded down $0.20 during trading on Tuesday, reaching $42.18. 82,909 shares of the company were exchanged, compared to its average volume of 111,820. The company has a quick ratio of 1.66, a current ratio of 2.90 and a debt-to-equity ratio of 1.62. Phibro Animal Health has a twelve month low of $32.05 and a twelve month high of $54.62. The stock has a market cap of $1.71 billion, a PE ratio of 24.24, a price-to-earnings-growth ratio of 3.55 and a beta of 0.82.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Monday, August 27th. The company reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.04. Phibro Animal Health had a return on equity of 39.81% and a net margin of 7.90%. The firm had revenue of $211.80 million during the quarter, compared to analysts’ expectations of $209.27 million. During the same period in the previous year, the firm earned $0.39 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. Analysts expect that Phibro Animal Health will post 1.75 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 19th. Shareholders of record on Wednesday, November 28th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.14%. This is a boost from Phibro Animal Health’s previous quarterly dividend of $0.10. The ex-dividend date is Tuesday, November 27th. Phibro Animal Health’s payout ratio is presently 22.99%.

In other Phibro Animal Health news, CEO Jack Bendheim sold 10,000 shares of the business’s stock in a transaction dated Tuesday, August 21st. The stock was sold at an average price of $50.35, for a total value of $503,500.00. Following the completion of the transaction, the chief executive officer now directly owns 60,000 shares of the company’s stock, valued at $3,021,000. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Daniel M. Bendheim sold 2,500 shares of the business’s stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $44.30, for a total value of $110,750.00. Following the completion of the transaction, the vice president now directly owns 2,500 shares of the company’s stock, valued at $110,750. The disclosure for this sale can be found here. Over the last three months, insiders sold 183,020 shares of company stock valued at $8,971,771. Insiders own 50.29% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Read More: What is the Rule of 72?

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with's FREE daily email newsletter.

Leave a Reply